pharmaceutical
FDA Approves First New Lupus Drug in Half a Century
7:15PM 3/09/2011
The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in 56 years. It's not terribly effective: It only worked for 35% of the patients tested. But experts say the approval could prompt the development of more effective drugs.
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.
The Problem with Fast-Tracking Drug Approvals: Pharmas Fail to Follow Up
8:00PM 2/09/2011
Health Care, Genzyme Corporation , GlaxoSmithKline, Novartis, Amgen, Eli Lilly
To get potentially lifesaving drugs to patients faster, the U.S. Food and Drug Administration is allowed to approve some drugs -- those that address unmet medical needs -- based on fewer trials than usual. But it turns out that many of the pharmaceutical companies fail to conduct follow-up trials to prove the drugs work.
Confirmed: Why Merck Halted Its Stroke-Victim Study
2:45AM 1/20/2011
When Merck halted a late-stage study of its potential clot-preventing drug vorapaxar in stroke victims last week, it didn't explain why. Now, the company has confirmed it stopped the study after concerns that the drug increased the risk of bleeding in some patients.
Which Sector Lost the Most Jobs in 2010? Pharma
10:15AM 1/07/2011
Mergers, acquisitions and major restructurings made Big Pharma a much smaller and leaner sector, with some 54,000 jobs lost. At least that's better than 2009's 61,000 layoffs.
AstraZeneca's Brilinta Fails to Win FDA Approval
8:08AM 12/17/2010
Company News, Health Care, Pfizer, Bristol-Myers Squibb, Sanofi Aventis, Astrazeneca, Stocks in the News
The FDA disappointed AstraZeneca and its investors by not approving its heart drug Brilinta, a blood-thinner that the company -- facing a severe patent cliff -- has high hopes for. If approved, it could be a multibillion-dollar blockbuster. But the FDA wants to see more analyses of results from a major study.
According to the latest leaked U.S. diplomatic cables from WikiLeaks, Pfizer hired investigators to try to uncover evidence of corruption in order to pressure the Nigerian attorney general to drop the case against it.
Johnson & Johnson Launches Offer for Crucell
10:45PM 12/08/2010
Company News, Health Care, Johnson & Johnson, Stocks in the News
As part of its efforts to expand into the biotech market, Johnson & Johnson is making a long-anticipated bid for Dutch vaccine maker Crucell -- in spite of Crucell's recent manufacturing troubles.
FDA Panel Backs Orexigen's Diet Pill
8:30PM 12/07/2010
After the U.S. Food and Drug Administration rejected two other weight-loss pills earlier this year, an advisory panel has recommended the approval of Orexigen Therapeutics's Contrave. If the FDA follows the recommendation, Contrave could become the first diet drug to win approval in a decade.
Novartis Halts Lung Cancer Drug Study
8:15AM 11/11/2010
Novartis will discontinue studies of an experimental lung-cancer cancer drug because of disappointing trial results.
More Stories
Next Page →Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.08 | -0.11 -1.28% | 184.54M | |
| 2.21 | +0.27 +13.66% | 107.06M | |
| 12.45 | -0.25 -1.93% | 35.97M | |
| 18.84 | -0.30 -1.54% | 33.77M |
% Gainers
| 31.71 | +7.81 +32.68% | 15.75M | |
| 89.60 | +13.21 +17.29% | 10.41M | |
| 2.21 | +0.27 +13.66% | 107.06M | |
| 10.55 | +1.15 +12.23% | 2.78M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Greek PM says default would lead to 'chaos'
- Budget deficit drops to $27 billion in January
- Turbo-traders take Bank of America for a ride
- Stocks fall sharply as Greek deal is held up
- Bernanke: Weak housing has hurt consumer...
- Trade deficit widens to $48.8 billion in...
- Feds investigate door fires in 2007 Camrys,...
- Review: Netflix and Hulu's new scripted...
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
- 2011 Trade Deficit Hits 3-Year High, Over $550 Billion
- Today’s Best Market Rumors (2/10/2012) Apple iPad, Google Entertainment
- Top Analyst Upgrades & Downgrades (ALTR, AMSC, BIIB, CELG, COH, CSTR, COP, FSLR, GILD, HAIN, MA, RF, TRLG)
Follow Us
